Adult brain tumour research in 2024: Status, challenges and recommendations.

Autor: Purshouse K; Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK., Bulbeck HJ; Brainstrust, Cowes, UK., Rooney AG; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK., Noble KE; Brain Tumour Research, Milton Keynes, UK., Carruthers RD; Beatson West of Scotland Cancer Centre, Glasgow, UK., Thompson G; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.; Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK., Hamerlik P; Division of Cancer Sciences, University of Manchester, Manchester, UK., Yap C; Clinical Trials and Statistics Unit, Sutton, UK., Kurian KM; Bristol Brain Tumour Research Centre, Bristol Medical School, University of Bristol, Bristol, UK., Jefferies SJ; Oncology Department, Addenbrooke's Hospital, Cambridge, UK., Lopez JS; Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK., Jenkinson MD; University of Liverpool & Walton Centre, Liverpool, UK., Hanemann CO; Peninsula Medical School, University of Plymouth, Plymouth, UK., Stead LF; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.

Publikováno v: Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2024 Apr; Vol. 50 (2), pp. e12979.

Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured

Autor: Noble, DJ, Ajithkumar, T, Lambert, J, Gleeson, I, Williams, MV, Jefferies, SJ

Publikováno v: Clinical Oncology (Royal College of Radiologists (Great Britain)

Aims Craniospinal irradiation (CSI) remains a crucial treatment for patients with medulloblastoma. There is uncertainty about how to manage meningeal surfaces and cerebrospinal fluid (CSF) that follows cranial nerves exiting skull base foramina. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b1cb68707b99520cd46d0ecbe197eb

An Evaluation of the Tolerability and Feasibility of Combining 5-Amino-Levulinic Acid (5-ALA) with BCNU Wafers in the Surgical Management of Primary Glioblastoma.

Autor: Watts C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Neurosurgery, Queen Elizabeth Hospital, Birmingham B15 2WB, UK., Ashkan K; Department of Neurosurgery, King's College Hospital, London SE5 9RS, UK., Jenkinson MD; Department of Neurosurgery, The Walton Centre, Liverpool L9 7LJ, UK.; Institute of Translational Medicine, University of Liverpool, Liverpool L69 3BX, UK., Price SJ; Academic Neurosurgery Department, University of Cambridge, Cambridge CB2 0QQ, UK., Santarius T; Department of Clinical Neurosciences, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK., Matys T; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK., Zhang TT; Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK., Finch A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK., Collins P; Department of Clinical Neurosciences, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK., Allinson K; Department of Histopathology, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK., Jefferies SJ; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK., Scoffings DJ; Department of Clinical Neurosciences, Cambridge University Hospitals Foundation Trust, Cambridge CB2 0QQ, UK., Zisakis A; Department of Neurosurgery, Queen Elizabeth Hospital, Birmingham B15 2WB, UK., Phillips M; Cancer Institute, University College London, London WC1E 6DD, UK., Wanek K; Cancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK., Smith P; Cancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK., Clifton-Hadley L; Cancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK., Counsell N; Cancer Research UK and University College London Cancer Trials Centre, London W1T 4TJ, UK.

Publikováno v: Cancers [Cancers (Basel)] 2021 Jun 29; Vol. 13 (13). Date of Electronic Publication: 2021 Jun 29.

Anatomical change during radiotherapy for head and neck cancer, and its effect on delivered dose to the spinal cord.

Autor: Noble DJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, UK. Electronic address: david.noble@addenbrookes.nhs.uk., Yeap PL; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Cavendish Laboratory, University of Cambridge, UK., Seah SYK; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Cavendish Laboratory, University of Cambridge, UK., Harrison K; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Cavendish Laboratory, University of Cambridge, UK., Shelley LEA; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Department of Engineering, University of Cambridge, UK; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK., Romanchikova M; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK., Bates AM; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Cambridge Clinical Trials Unit, Box 401, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, UK., Zheng Y; University of Cambridge School of Clinical Medicine, UK; Department of Medicine, Cheltenham General Hospital, UK., Barnett GC; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, UK., Benson RJ; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, UK., Jefferies SJ; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, UK., Thomas SJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK., Jena R; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, UK; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, UK., Burnet NG; University of Manchester, Manchester Academic Health Science Centre and The Christie NHS Foundation Trust, Manchester, UK.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2019 Jan; Vol. 130, pp. 32-38. Date of Electronic Publication: 2018 Jul 23.

Tumour Volume and Dose Influence Outcome after Surgery and High-dose Photon Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine.

Autor: Gatfield ER; Oncology Centre, Addenbrooke's Hospital, Cambridge, UK. Electronic address: elinor.gatfield@nhs.net., Noble DJ; University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, UK., Barnett GC; Oncology Centre, Addenbrooke's Hospital, Cambridge, UK., Early NY; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK., Hoole ACF; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK., Kirkby NF; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK., Jefferies SJ; Oncology Centre, Addenbrooke's Hospital, Cambridge, UK., Burnet NG; University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, UK.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2018 Apr; Vol. 30 (4), pp. 243-253.